Free Trial

Windtree Therapeutics (WINT) SEC Filings & 10K Form

Windtree Therapeutics logo
$4.35 -0.45 (-9.38%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$4.45 +0.10 (+2.30%)
As of 02/21/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Windtree Therapeutics SEC Filings

DateFilerForm TypeView
02/18/2025
7:10 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:20 PM
Windtree Therapeutics (Filer)
Form 8-K/A
02/14/2025
3:44 PM
ARMISTICE CAPITAL, LLC (Filed by)
Windtree Therapeutics (Subject)
Form SCHEDULE 13G/A
02/03/2025
4:20 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
4:05 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:09 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:25 PM
Windtree Therapeutics (Filer)
Form DEF 14A
01/08/2025
7:05 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
5:03 AM
Windtree Therapeutics (Filer)
Form PRE 14A
12/05/2024
6:12 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2024
7:02 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:43 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
3:46 PM
Windtree Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/15/2024
3:32 PM
Windtree Therapeutics (Filer)
Form 8-K/A
11/15/2024
3:30 PM
Windtree Therapeutics (Filer)
Form NT 10-Q
11/14/2024
6:15 PM
Lind Global Fund II LP (Filed by)
Windtree Therapeutics (Subject)
Form SC 13G/A
11/14/2024
7:53 AM
Flynn James E (Filed by)
Windtree Therapeutics (Subject)
Form SC 13G/A
11/14/2024
7:01 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
6:46 AM
Fraser Craig (Reporting)
Windtree Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:27 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
4:28 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
7:55 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:22 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
7:05 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
4:21 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
4:26 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
11:15 PM
Windtree Therapeutics (Filer)
Form EFFECT
09/03/2024
11:15 PM
Windtree Therapeutics (Filer)
Form EFFECT
09/03/2024
8:09 AM
Windtree Therapeutics (Filer)
Form 424B5
09/03/2024
8:10 AM
Windtree Therapeutics (Filer)
Form 424B5
09/03/2024
6:26 AM
Windtree Therapeutics (Filer)
Form ARS
09/03/2024
6:22 AM
Windtree Therapeutics (Filer)
Form DEF 14A
08/23/2024
3:15 PM
Windtree Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/21/2024
3:55 PM
Windtree Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/20/2024
7:44 PM
Windtree Therapeutics (Filer)
Form PRE 14A
08/20/2024
3:30 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
3:24 PM
PELLETIER SAUNDRA L (Reporting)
Windtree Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/29/2024
7:33 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
3:07 PM
Windtree Therapeutics (Filer)
Form RW
07/24/2024
4:27 PM
Fraser Craig (Reporting)
Windtree Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
4:28 PM
Simonson Steven (Reporting)
Windtree Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Watch This Robotics Demo Before March 17th (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

07/22/2024
8:25 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:53 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
8:11 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
3:59 PM
Windtree Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:41 AM
Windtree Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/21/2024
11:15 PM
Windtree Therapeutics (Filer)
Form EFFECT
04/17/2024
4:03 PM
Windtree Therapeutics (Filer)
Form S-3/A
04/17/2024
6:30 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
4:16 PM
Windtree Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/10/2024
3:37 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
3:33 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
4:29 PM
Windtree Therapeutics (Filer)
Form NT 10-K
03/12/2024
4:13 PM
Windtree Therapeutics (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:WINT) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners